Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer

NCT06284746 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Gastric Carcinoma
HER2 Negative
Efficacy
Safety

Interventions

DRUG: Tirolizumab+SOX/XELOX
DRUG: SOX/XELOX

Sponsor

Lin Chen